Smith-Magenis Syndrome Treatment Market The France Smith-Magenis Syndrome Treatment Market was valued at approximately €XX million in 2022, with an anticipated compound annual growth rate (CAGR) of XX% during the forecast period. This market reflects the growing recognition of Smith-Magenis Syndrome (SMS) and the increasing demand for effective therapeutic interventions. […]
Recent News